Document Detail


Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin.
MedLine Citation:
PMID:  20572767     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Host modulatory therapy has been proposed as a treatment for periodontal diseases. Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs), including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), were shown to have therapeutic anti-inflammatory and protective actions in inflammatory diseases including periodontitis. The goal of this study was to test an innovative strategy for periodontal treatment in a clinical experiment.
METHODS: Eighty healthy subjects (40 in each group) with advanced chronic periodontitis were enrolled in Mansoura, Egypt, in a parallel-design, double-masked clinical study. The control group was treated with scaling and root planing (SRP) and a placebo, whereas the ω-3 group was treated with SRP followed by dietary supplementation of fish oil (900 mg EPA + DHA) and 81 mg aspirin daily. Saliva samples were obtained from all patients at baseline and 3 and 6 months for evaluation of receptor activator of nuclear factor-kappa B ligand (RANKL) and matrix metalloproteinase-8 (MMP-8). Plaque and gingival indices, bleeding on probing, probing depths, and attachment levels were recorded at the same time points.
RESULTS: Statistical analyses demonstrated a significant reduction in probing depths and a significant attachment gain after 3 and 6 months in the ω-3 group compared to baseline and the control group (P <0.05). Salivary RANKL and MMP-8 levels showed significant reductions in the ω-3 group in response to treatment at 3 and 6 months and compared to the control group at 6 months (P <0.01). Supplementation with ω-3 + aspirin resulted in a significant shift in the frequency of pockets with probing depths <4 mm (P <0.05).
CONCLUSION: The results of this preliminary clinical study suggest that dietary supplementation with ω-3 PUFAs and 81 mg aspirin may provide a sustainable, low-cost intervention to augment periodontal therapy.
Authors:
Hesham El-Sharkawy; Nayer Aboelsaad; Mohamed Eliwa; Mahmoud Darweesh; Mohammad Alshahat; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Related Documents :
15484157 - Month-to-month and year-to-year reproducibility of high frequency qrs ecg signals.
1453307 - Guided tissue regeneration versus mucogingival surgery in the treatment of human buccal...
11759857 - Comparison of 2 techniques of subepithelial connective tissue graft in the treatment of...
15966877 - Healing of intra-bony defects following treatment with a composite bovine-derived xenog...
22335867 - Discharge patterns after radical cystectomy: contemporary trends in the united states.
7822917 - Initial treatment of closed metacarpal fractures. a controlled comparison of compressio...
Publication Detail:
Type:  Journal Article     Date:  2010-06-23
Journal Detail:
Title:  Journal of periodontology     Volume:  81     ISSN:  1943-3670     ISO Abbreviation:  J. Periodontol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8000345     Medline TA:  J Periodontol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1635-43     Citation Subset:  D; IM    
Affiliation:
Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University, Mansoura, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gingival RAGE expression in calorie-restricted versus ad libitum-fed rats.
Next Document:  Application of a motivation-behavioral skills protocol in gingival lichen planus: a short-term study...